Arrow Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-795
Closed -$35K 352
2022
Q1
$35K Hold
795
﹤0.01% 236
2021
Q4
$34K Hold
795
﹤0.01% 230
2021
Q3
$34K Hold
795
﹤0.01% 234
2021
Q2
$34K Hold
795
﹤0.01% 242
2021
Q1
$31K Hold
795
﹤0.01% 242
2020
Q4
$29K Hold
795
0.01% 230
2020
Q3
$30K Hold
795
0.01% 220
2020
Q2
$28K Sell
795
-205
-21% -$7.38K 0.01% 233
2020
Q1
$33K Hold
1,000
0.01% 225
2019
Q4
$45K Hold
1,000
0.01% 226
2019
Q3
$41K Sell
1,000
-6,500
-87% -$275K 0.01% 230
2019
Q2
$323K Buy
7,500
+200
+3% +$7.69K 0.07% 139
2019
Q1
$280K Buy
+7,300
New +$279K 0.06% 154
2015
Q4
Sell
-265
Closed -$4K 515
2015
Q3
$4K Hold
265
﹤0.01% 318
2015
Q2
$5K Hold
265
﹤0.01% 312
2015
Q1
$5K Hold
265
﹤0.01% 326
2014
Q4
$4K Hold
265
﹤0.01% 325
2014
Q3
$3K Hold
265
﹤0.01% 381
2014
Q2
$3K Hold
265
﹤0.01% 330
2014
Q1
$4K Sell
265
-100
-27% -$1.31K ﹤0.01% 326
2013
Q4
$4K Hold
365
﹤0.01% 318
2013
Q3
$4K Buy
365
+100
+38% +$1.08K ﹤0.01% 311
2013
Q2
$2K Buy
+265
New +$2.25K ﹤0.01% 328

Other funds holding BSX

Arrow Financial's BSX Position: Q2 2022 in Review

Arrow Financial sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 795 shares — an estimated $35K sold.

Arrow Financial first reported a position in BSX in Q2 2013 and held it in 23 quarters. The position peaked at $323K in Q2 2019. 880 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • Arrow Financial reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
  • Arrow Financial sold 795 Boston Scientific shares in Q2 2022, an estimated $35K.
  • Arrow Financial first reported a position in Boston Scientific in Q2 2013 and held it in 23 quarters.
  • Arrow Financial's Boston Scientific position peaked at $323K in Q2 2019.
  • 880 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Arrow Financial's 13F filing for Q2 2022, filed 25 Jul 2022.